跳转至内容
Merck
CN

R103

利坦丝林

powder

别名:

6-[2- [4-(双(4-氟苯基)亚甲基] -1-哌啶基]乙基] -7-甲基-5H-噻唑并[3,2-a]嘧啶-5-酮

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C27H25F2N3OS
化学文摘社编号:
87051-43-2
分子量:
477.57
NACRES:
NA.77
PubChem Substance ID:
24278117
UNSPSC Code:
12352200
MDL number:
MFCD00069341
Form:
powder
Quality level:
200

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3

SMILES string

CC1=C(CCN2CCC(\CC2)=C(\c3ccc(F)cc3)c4ccc(F)cc4)C(=O)N5C=CSC5=N1

InChI key

JUQLTPCYUFPYKE-UHFFFAOYSA-N

form

powder

color

white

solubility

methanol: >10 mg/mL, DMSO: >10.1 mg/mL, 2-hydroxypropyl-β-cyclodextrin: insoluble, H2O: insoluble, dilute aqueous base: insoluble

Quality Level

200

Gene Information

human ... HTR2A(3356)
rat ... Adra1a(29412), Drd2(24318), Htr1a(24473), Htr2a(29595), Htr7(65032)

正在寻找类似产品? 访问 产品对比指南

Application

利坦色林已用于行为测试，并用作 5-羟色胺 2A 受体（5-HT2A）受体拮抗剂。

Biochem/physiol Actions

利坦色林是有效的 5-羟色胺 2A 受体（5-HT2A）羟色胺受体拮抗剂/反向激动剂，可穿过血脑屏障。它调节 5-HT 2A 受体，并被认为具有抗帕金森作用。利坦色林还通过调节情绪、认知和消极症状来影响精神分裂症。
有效的 5-HT2A 5-羟色胺受体拮抗剂/反向激动剂，可穿越血脑屏障。

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000214592
0000214594
0000214595
0000214594
0000214592

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone
Hashimoto H, et al.
Journal of Neurochemistry, 110(2), 595-602 (2009)
Anna Sławińska et al.
Neuropharmacology, 66, 225-235 (2012-05-29)
Previous studies demonstrated that the Group III mGlu receptor-selective orthosteric agonist, LSP1-2111 produced anxiolytic- but not antidepressant-like effects upon peripheral administration. Herein, we report the pharmacological actions of Lu AF21934, a novel, selective, and brain-penetrant positive allosteric modulator (PAM) of
K Stachowicz et al.
Neuropharmacology, 57(3), 227-234 (2009-06-23)
Our earlier studies have demonstrated that (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid ACPT-I, a group III mGlu receptor agonist, produced anxiolytic-like and antidepressant-like actions after central administration. Here we describe the anxiolytic-like effects of ACPT-I after intraperitoneal administration in the stress-induced hyperthermia (SIH), elevated
Marcus C Ferguson et al.
Neuropharmacology, 59(1-2), 31-36 (2010-04-07)
Clinical observations have suggested that ritanserin, a 5-HT(2A/C) receptor antagonist may reduce motor deficits in persons with Parkinson's Disease (PD). To better understand the potential antiparkinsonian actions of ritanserin, we compared the effects of ritanserin with the selective 5-HT(2A) receptor
Modulation by 5-HT2A receptors of aggressive behavior in isolated mice
Sakaue M, et al.
Japanese Journal of Pharmacology, 89(1), 89-92 (2002)
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持